Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Glioblastoma 94Glioma 32Brain Neoplasms 29Melanoma 21Neoplasms 17Astrocytoma 17Sarcoma, Ewing 7Ovarian Neoplasms 7Gliosarcoma 7Carcinoma, Non-Small-Cell Lung 7Neuroblastoma 6Neoplasm Metastasis 6Medulloblastoma 6Breast Neoplasms 6Sarcoma 5Recurrence 5Diffuse Intrinsic Pontine Glioma 5Small Cell Lung Carcinoma 4Rhabdomyosarcoma 4Oligodendroglioma 4Spinal Cord Neoplasms 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Central Nervous System Neoplasms 3Triple Negative Breast Neoplasms 2Rhabdoid Tumor 2Neuroendocrine Tumors 2Lymphoma, Follicular 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2

Interventions

pembrolizumab 15Nivolumab 10Ipilimumab 7cemiplimab 6dabrafenib 4binimetinib 4Dacarbazine 4trametinib 3encorafenib 3Drug Therapy 3Allovectin-7 3zanolimumab 2talabostat 2lifileucel 2aldesleukin 2Vemurafenib 2Tablets 2Semaxinib 2Intravital Microscopy 2Interleukin-2 2Fluorouracil 2vitespin 1veliparib 1varlilumab 1tozuleristide 1tin etiopurpurin 1tilsotolimod 1spartalizumab 1sotigalimab 1sonidegib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Skin Neoplasms × Temozolomide × Clear all
NCT00804908 2018-06-06

A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma

AbbVie

Phase 2 Completed
346 enrolled 15 charts
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡